# CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) FY2026 Q2 Balance Sheet

- Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
- Period: As of 2026-06-27
- Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001100682-26-000118
- Page: https://plicit.ai/financials/crl/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/crl-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-27. The chart shows assets, liabilities and equity at that date.

- **Assets**: 7,532,145,000 US dollars
- **Current assets**: 1,529,106,000 US dollars
- **Non-current assets**: 6,003,039,000 US dollars
- **Liabilities**: 4,643,618,000 US dollars
- **Current liabilities**: 1,134,746,000 US dollars
- **Non-current liabilities**: 3,508,872,000 US dollars
- **Equity**: 2,845,990,000 US dollars
- **Redeemable noncontrolling interests**: 42,537,000 US dollars
- **Noncontrolling interest**: 6,354,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Trade receivables and contract assets, net of allowances for credit losses of $8,715 and $10,463, respectively**: 711,755,000 US dollars
- **Inventories**: 346,260,000 US dollars
- **Cash and cash equivalents**: 192,025,000 US dollars
- **Other current assets**: 178,657,000 US dollars
- **Prepaid assets**: 100,409,000 US dollars
- **Goodwill**: 3,076,851,000 US dollars
- **Property, plant and equipment, net**: 1,494,914,000 US dollars
- **Other assets**: 587,556,000 US dollars
- **Operating lease right-of-use assets, net**: 330,247,000 US dollars
- **Intangible assets, net**: 253,174,000 US dollars
- **Venture capital and strategic equity investments**: 206,470,000 US dollars
- **Deferred tax assets**: 53,827,000 US dollars
- **Accrued liabilities**: 380,101,000 US dollars
- **Other current liabilities**: 222,792,000 US dollars
- **Deferred revenue**: 203,035,000 US dollars
- **Accrued compensation**: 187,835,000 US dollars
- **Accounts payable**: 140,983,000 US dollars
- **Long-term debt, net and finance leases**: 2,619,985,000 US dollars
- **Operating lease right-of-use liabilities**: 407,708,000 US dollars
- **Other long-term liabilities**: 402,511,000 US dollars
- **Deferred tax liabilities**: 78,668,000 US dollars
- **Additional paid-in capital**: 1,986,023,000 US dollars
- **Retained earnings**: 1,372,295,000 US dollars
- **Common stock, $0.01 par value; 120,000 shares authorized; 49,550 shares issued and 47,728 shares outstanding as of June 27, 2026, and 49,217 shares issued and outstanding as of December 27, 2025**: 496,000 US dollars
- **Preferred stock, $0.01 par value; 20,000 shares authorized; no shares issued and outstanding**: 0 US dollars
- **Nonredeemable noncontrolling interest**: 6,354,000 US dollars
- **Treasury stock, at cost, 1,822 and zero shares, as of June 27, 2026 and December 27, 2025, respectively**: negative 323,189,000 US dollars
- **Accumulated other comprehensive loss**: negative 195,989,000 US dollars
- **Gross equity (calculated)**: 3,365,168,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus temporary equity plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.